UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2017
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
Commission File Number: 0-8765
BIOMERICA, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 95-2645573
--------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.
17571 Von Karman Avenue, Irvine, CA 92614
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number including area code: (949) 645-2111
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report.)
(TITLE OF EACH CLASS) (NAME OF EACH EXCHANGE ON WHICH REGISTERED)
--------------------- -------------------------------------------
Common, par value $.08 NASDAQ Capital Market
Securities registered pursuant to Section 12(g) of the Act:
(TITLE OF EACH CLASS)
COMMON STOCK, PAR VALUE $0.08
Indicate by check whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [_]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (paragraph 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X] No [_]
Indicate by check mark whether the registrant is a large accelerated, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer", "accelerated filer", and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer [_] Accelerated Filer [_]
Non-Accelerated Filer [_] Smaller Reporting Company [X]
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes [_] No [X]
Indicate the number of shares outstanding of each of the registrant's common stock, as of the latest practicable date: 8,541,048 shares of common stock, par value $0.08, as of January 11, 2018.
PURPOSE OF AMENDMENT
The sole purpose of this amendment to our Quarterly Report on Form 10-Q for the quarterly period ended November 30, 2017, originally filed with the Securities and Exchange Commission on January 16, 2018, is to furnish Exhibit 101 (which was omitted from the original filing due to transmission issues) to the Form 10-Q, which contains the XBRL (eXtensible Business Reporting Language) Interactive Data File for the financial statements and notes included in Part I, Item 1 of the Form 10-Q.
As permitted by Rule 405(a)(2)(ii) of Regulation S-T, Exhibit 101 is required to be furnished by amendment within 30 days of the original filing date of the Form 10-Q.
No other changes have been made to the Form 10-Q and the Form 10-Q has not been updated to reflect events occurring subsequent to the original filing date.
Item 6. EXHIBITS.
The following exhibits are filed or furnished as part of this quarterly report on Form 10-Q/A:
| Exhibit No. |
| Description | |
|
| |||
31.1 | * | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Zackary S. Irani | ||
31.2 | * | Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Janet Moore | ||
32.1 | * | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act — Zackary S. Irani | ||
32.2 | * | Certification Pursuant to Section 906 of the Sarbanes-Oxley Act – Janet Moore | ||
101 | ** | XBRL Financials | ||
* | Previously filed. | |||
** | Filed herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has fully caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BIOMERICA, INC.
Date: January 17, 2018
By: /S/ Zackary S. Irani
-----------------------
Zackary S. Irani
Chief Executive Officer
(Principal Executive Officer)
Date: January 17, 2018
By: /S/ Janet Moore
-----------------------
Janet Moore
Chief Executive Officer
(Principal Financial Officer)
